Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients
- PMID: 28366509
- PMCID: PMC5465639
- DOI: 10.1016/j.chom.2017.03.003
Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients
Abstract
Despite the immune-reconstitution with antiretroviral therapy (ART), HIV-infected individuals remain highly susceptible to tuberculosis (TB) and have an enrichment of oral anaerobes in the lung. Products of bacterial anaerobic metabolism, like butyrate and other short-chain fatty acids (SCFAs), induce regulatory T cells (Tregs). We tested whether SCFAs contribute to poor TB control in a longitudinal cohort of ART-treated HIV-infected South Africans. Increase in serum SCFAs was associated with increased TB susceptibility. SCFAs inhibited IFN-γ and IL-17A production in peripheral blood mononuclear cells from HIV-infected ART-treated individuals in response to M. tuberculosis antigen stimulation. Pulmonary SCFAs correlated with increased oral anaerobes, such as Prevotella in the lung, and with M. tuberculosis antigen-induced Tregs. Metabolites from anaerobic bacterial fermentation may, therefore, increase TB susceptibility by suppressing IFN-γ and IL-17A production during the cellular immune response to M. tuberculosis.
Keywords: FoxP1; FoxP3; HIV; dysbiosis; lung; short-chain fatty acids; tuberculosis.
Copyright © 2017 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Comment in
-
HIV-associated anaerobes ferment TB risk.Sci Transl Med. 2017 May 10;9(389):eaan3781. doi: 10.1126/scitranslmed.aan3781. Sci Transl Med. 2017. PMID: 28490669
References
-
- Borgdorff H, Gautam R, Armstrong SD, Xia D, Ndayisaba GF, van Teijlingen NH, Geijtenbeek TB, Wastling JM, van de Wijgert JH. Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier. Mucosal immunology. 2016;9:621–633. - PubMed
-
- Bourriaud C, Robins RJ, Martin L, Kozlowski F, Tenailleau E, Cherbut C, Michel C. Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident. J Appl Microbiol. 2005;99:201–212. - PubMed
-
- Cailliez F. The analytical solution of the additive constant problem. Psychometrika. 1983;48:305–310.
MeSH terms
Substances
Grants and funding
- K24 HL123342/HL/NHLBI NIH HHS/United States
- UL1 TR001445/TR/NCATS NIH HHS/United States
- P30 CA016087/CA/NCI NIH HHS/United States
- R01 HL090316/HL/NHLBI NIH HHS/United States
- K24 AI080298/AI/NIAID NIH HHS/United States
- K23 AI102970/AI/NIAID NIH HHS/United States
- R01 HL090313/HL/NHLBI NIH HHS/United States
- P30 DK020541/DK/NIDDK NIH HHS/United States
- U24 DK097153/DK/NIDDK NIH HHS/United States
- UL1 TR000038/TR/NCATS NIH HHS/United States
- R01 HL057879/HL/NHLBI NIH HHS/United States
- R01 HL125049/HL/NHLBI NIH HHS/United States
- U01 CA086137/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
